07:00 , Jun 30, 2016 |  BC Innovations  |  Distillery Techniques

Techniques: A 15-microRNA (miRNA) signature to predict survival in patients with colon, pancreatic and stomach cancers

Biomarkers TECHNOLOGY: Gene profiling A 15-microRNA signature associated with high doublecortin-like kinase 1 (DCLK1) activity could help predict survival in colon, pancreatic and stomach cancers. In colon, esophageal, pancreatic, rectal and stomach tumor samples from patients, high...
07:00 , Aug 13, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-194 (miR-194)

Cancer INDICATION: Liver cancer In vitro, mouse and patient sample studies suggest miR-194 could help prevent metastasis of hepatocellular carcinoma (HCC). In tumor samples from HCC patients and five HCC cell lines, miR-194 levels were lower than...
07:00 , Oct 28, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) MicroRNA-192 (miR-192); miR-194; miR-215; MDM2 p53 binding protein homolog (MDM2; HDM2) Cell culture and...